On the August 2, 2024 episode of NHK World's "jib TV," titled "Innovation in Amino Acids," Ajinomoto Group's advanced amino acid technologies were featured. In the episode, Heartseed's CEO, Keiichi Fukuda, spoke about the results of long-term collaboration research, including the technology for producing high-quality cardiomyocytes and the importance of culture mediums for the societal implementation of cardiac regeneration medicine.

This program is viewable by approximately 337 million households worldwide (as of the end of June 2024). You can also view the broadcast on this website (The segment related to iPS cells starts around 9:00).